143 related articles for article (PubMed ID: 26631321)
1. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity.
Brown GD; Shi Q; Delucca GV; Batt DG; Galella MA; Cvijic ME; Liu RQ; Qiu F; Zhao Q; Barrish JC; Carter PH
Bioorg Med Chem Lett; 2016 Jan; 26(2):662-666. PubMed ID: 26631321
[TBL] [Abstract][Full Text] [Related]
2. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J
Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662
[TBL] [Abstract][Full Text] [Related]
4. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
[TBL] [Abstract][Full Text] [Related]
5. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2).
Strunz AK; Zweemer AJ; Weiss C; Schepmann D; Junker A; Heitman LH; Koch M; Wünsch B
Bioorg Med Chem; 2015 Jul; 23(14):4034-49. PubMed ID: 25766632
[TBL] [Abstract][Full Text] [Related]
7. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
[TBL] [Abstract][Full Text] [Related]
8. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
[TBL] [Abstract][Full Text] [Related]
9. Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy.
Qin LH; Wang ZL; Xie X; Long YQ
Bioorg Med Chem; 2018 Jul; 26(12):3559-3572. PubMed ID: 29805075
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.
Vilums M; Zweemer AJ; Dekkers S; Askar Y; de Vries H; Saunders J; Stamos D; Brussee J; Heitman LH; IJzerman AP
Bioorg Med Chem Lett; 2014 Dec; 24(23):5377-80. PubMed ID: 25453791
[TBL] [Abstract][Full Text] [Related]
11. Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.
Carter PH
Expert Opin Ther Pat; 2013 May; 23(5):549-68. PubMed ID: 23428142
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
[TBL] [Abstract][Full Text] [Related]
13. Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists.
Cai C; McComsey DF; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
Bioorg Med Chem Lett; 2014 Feb; 24(4):1239-42. PubMed ID: 23916257
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
[TBL] [Abstract][Full Text] [Related]
15. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
[TBL] [Abstract][Full Text] [Related]
18. Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Mo R; Meyer DT; Pechulis AD; Guaciaro MA; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Cvijic ME; Barrish JC; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2012 Oct; 22(19):6181-4. PubMed ID: 22939233
[TBL] [Abstract][Full Text] [Related]
19. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone.
Carter PH; Brown GD; King SR; Voss ME; Tebben AJ; Cherney RJ; Mandlekar S; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Decicco CP
Bioorg Med Chem Lett; 2012 May; 22(9):3311-6. PubMed ID: 22475558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
